Ingredion shares slipped 0.5% to $102.78 at the latest close. The latest filing offers a less tidy fact pattern: sales edged higher, but the money left after making them fell sharply.
For the three months ended June 30, revenue rose 0.9% to $1.9 billion from $1.8 billion a year earlier. Gross profit fell 10.7% to $426 million, operating income dropped 30.6% to $188 million, and net income fell 41.8% to $114 million. The company sold slightly more and kept much less of it.
Gross margin narrowed to 23.0% from 26.0%. Operating margin fell to 10.2% from 14.8%. Ingredion’s diluted share count also declined 2.6%, but that was not enough to prevent diluted earnings per share from falling 40.5%, to $1.78.
The company’s explanations vary across its businesses. Some sales benefited from higher volumes and foreign exchange, but price mix worked against them:
"The increase was primarily due to higher volumes and favorable foreign exchange impacts, partially offset by unfavorable price mix."
Ingredion, 10-Q, August 7, 2026
That is the first part of the trade-off: volume and currency helped the top line, while the combination of what Ingredion sold and the prices attached to it did less for profitability. The currency benefit is also a reminder that a little revenue growth is not necessarily all operating improvement.
Elsewhere, the filing identifies a more concrete operating problem at the Argo facility:
"The decrease was primarily due to lower volumes from production challenges at our Argo facility and unfavorable price mix."
Ingredion, 10-Q, August 7, 2026
Ingredion does not quantify Argo’s contribution to the consolidated decline in the supplied filing data. It does disclose the result at group level: a 3.0-point drop in gross margin and a 4.5-point decline in net margin.
The balance sheet adds another wrinkle. Cash rose 10.1% to $948 million, while inventory fell 9.3% to $1.1 billion. But capital spending rose 8.8% year over year, and free-cash-flow margin declined 4.3 percentage points. The cash balance was higher at the reporting date, while the period’s cash conversion was weaker.
That matters because Ingredion is not coming from a history of uniformly thin margins. Its annual results show operating margin reaching 14.1% in 2025, up from 11.9% in 2024, even as revenue fell 2.8% to $7.2 billion. The latest three months put that margin recovery under pressure without requiring a large sales decline.
The broader pattern in the company’s disclosures also keeps volume and price mix on the watch list. Demand and volume have carried adverse evidence across five filings, while input and raw-material costs have done so across four. That history does not explain this quarter by itself, but it makes the Argo and mix references more specific than a one-line margin wobble.
Ingredion’s next quarterly report will add the useful comparison: whether Argo’s production challenges, volume, and price mix are still named alongside the consolidated gross margin. For now, the filing presents a more complicated pattern: more sales, fewer dollars left over.
Ingredion’s August 7, 2026 10-Q reports higher revenue alongside lower volumes from Argo production challenges, unfavorable price mix, and narrower margins.